We are live on
!
Find out more
NSEDCP
NJ State Employees Deferred Compensation Plan Portfolio holdings
AUM
$906M
1-Year Est. Return
24.85%
This Fund
S&P 500
This Quarter
Est. Return
-0.14%
1 Year Est. Return
+24.85%
3 Year Est. Return
+127.22%
5 Year Est. Return
+201.43%
10 Year Est. Return
+564.84%
AUM
$737M
AUM Growth
-$15.3M
(-2%)
Cap. Flow
-$5.45M
Cap. Flow
% of AUM
-0.74%
Top 10 Holdings %
Top 10 Hldgs %
24.74%
Holding
518
New
2
Increased
5
Reduced
1
Closed
14
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AstraZeneca
AZN
|
+$1.11M |
| 2 |
Sphere Entertainment
SPHR
|
+$245K |
| 3 |
NSLR
Neostellar Capital Corp
NSLR
|
+$23.5K |
| 4 |
Danaher
DHR
|
+$272 |
| 5 |
GE Aerospace
GE
|
+$64 |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ALXN
Alexion Pharmaceuticals
ALXN
|
+$1.65M |
| 2 |
Zurn Elkay Water Solutions
ZWS
|
+$1.1M |
| 3 |
NAV
Navistar International
NAV
|
+$623K |
| 4 |
QTS
QTS REALTY TRUST, INC.
QTS
|
+$618K |
| 5 |
Microsoft
MSFT
|
+$495K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 24.79% |
| 2 | Financials | 14.06% |
| 3 | Healthcare | 12.76% |
| 4 | Industrials | 11.98% |
| 5 | Communication Services | 9.28% |
Similar funds
IAM
BFS
MSAM
SAM
CP
EAM
HWM
BVDMP
NJ State Employees Deferred Compensation Plan's Q3 2021 Portfolio in Review
As of Q3 2021, NJ State Employees Deferred Compensation Plan held 518 positions worth $737M, down 2% from $752M the previous quarter. Its ten largest holdings account for 25% of the portfolio.
Trading was light in Q3 2021: portfolio turnover was 3.1%. NJ State Employees Deferred Compensation Plan opened 2 new positions and exited 14, leaving the 518-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 25% of assets, up from 24% a quarter earlier, followed by Financials and Healthcare.
- NJ State Employees Deferred Compensation Plan's largest Q3 2021 buy was AstraZeneca: 9,560 shares worth $1.15M.
- NJ State Employees Deferred Compensation Plan added most to Neostellar Capital Corp in Q3 2021, an estimated $23.5K increase.
- NJ State Employees Deferred Compensation Plan's biggest Q3 2021 reduction was Microsoft, cutting an estimated $495K.
- NJ State Employees Deferred Compensation Plan fully exited Alexion Pharmaceuticals in Q3 2021, selling an estimated $1.65M.
- NJ State Employees Deferred Compensation Plan's ten largest holdings make up 25% of its $737M portfolio in Q3 2021.
- NJ State Employees Deferred Compensation Plan opened 2 new positions and closed 14 in Q3 2021.
- NJ State Employees Deferred Compensation Plan's portfolio value fell 2% quarter-over-quarter to $737M.
Based on NJ State Employees Deferred Compensation Plan's 13F filing for Q3 2021, filed 26 Oct 2021.